Please enable JavaScript to continue using this application.

Compare $BMRN vs $TWST | Chartloom

Compare

$BMRN vs $TWST

BioMarin Pharmaceutical Inc · Twist Bioscience Corp

BMRN

BioMarin Pharmaceutical Inc

TWST

Twist Bioscience Corp

Compare $BMRN vs $TWST

Comparing BioMarin Pharmaceutical Inc and Twist Bioscience Corp

BMRNBioMarin Pharmaceutical Inc

TWSTTwist Bioscience Corp

BMRNBioMarin Pharmaceutical Inc

Market cap

$10.59B

P/E (TTM)

146.03x

Forward P/E (NTM)

12.82x

Forward P/S (NTM)

2.41x

Rev growth (TTM)

11.2%

YTD performance

-7.8%

52W performance

0.2%

FCF yield

6.8%

TWSTTwist Bioscience Corp

Market cap

$9.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.83x

Rev growth (TTM)

19.2%

YTD performance

393.3%

52W performance

387.3%

FCF yield

-1.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMRN

TWST

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

TWST

Twist Bioscience Corp

Market Cap

BMRN$10.59B

TWST$9.95B

Enterprise Value

BMRN$13.90B

TWST$9.83B

Price

BMRN$54.80

TWST$159.78

P/E Ratio

BMRN146.03x

TWSTN/A

P/S Ratio

BMRN3.11x

TWST23.04x

EV/Sales

BMRN4.08x

TWST22.77x

EV/EBITDA

BMRN16.77x

TWST0.00x

P/B Ratio

BMRN1.75x

TWST27.87x

P/FCF Ratio

BMRN14.61x

TWSTN/A

EV/FCF

BMRN19.17x

TWST-100.10x

PEG Ratio

BMRN4.10x

TWSTN/A

Forward P/E (NTM)

BMRN12.82x

TWSTN/A

Forward P/S (NTM)

BMRN2.41x

TWST18.83x

Revenue (TTM)

BMRN$3.41B

TWST$432M

Revenue Growth (YoY)

BMRN11.2%

TWST19.2%

Forward Rev Growth

BMRN14.5%

TWST15.0%

Gross Margin (TTM)

BMRN79.6%

TWST52.0%

Operating Margin (TTM)

BMRN4.4%

TWST0.0%

EBITDA Margin (TTM)

BMRN24.3%

TWST-26.0%

Net Margin (TTM)

BMRN2.1%

TWST-31.7%

FCF Margin (TTM)

BMRN21.3%

TWST-22.7%

Net Income (TTM)

BMRN$73M

TWST$-137M

FCF (TTM)

BMRN$725M

TWST$-98M

EPS (TTM)

BMRN$0.38

TWST-$2.19

ROE (TTM)

BMRN1.2%

TWST-2989.0%

ROA (TTM)

BMRN82.0%

TWST-2080.0%

ROIC (TTM)

BMRN93.0%

TWST-2989.0%

Cash

BMRN$874M

TWST$117M

Debt

BMRN$4.19B

TWST$0

Net Cash/Debt

BMRN$-3.31B

TWST$117M

Current Ratio (TTM)

BMRN2.39x

TWST2.67x

Quick Ratio (TTM)

BMRN1.16x

TWST2.30x

Debt/Equity (TTM)

BMRN0.66x

TWST0.00x

Debt/Assets (TTM)

BMRN0.0%

TWST0.0%

Interest Coverage (TTM)

BMRNN/A

TWSTN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

TWST0.00x

Beta

BMRN0.23

TWST2.17

52W Performance

BMRN0.2%

TWST387.3%

YTD Performance

BMRN-7.8%

TWST393.3%

% from 52W High

BMRN-22.8%

TWST-27.3%

% from 52W Low

BMRN11.2%

TWST585.8%

Asset Turnover (TTM)

BMRN0.38x

TWST0.66x

FCF Yield (TTM)

BMRN6.8%

TWST-1.0%

Earnings Yield (TTM)

BMRN0.7%

TWST-1.4%

Dividend Yield (TTM)

BMRNN/A

TWSTN/A

Rule of 40

BMRN32.5

TWST-3.6

EV/GP/RG

BMRN0.18

TWST1.94

Ticker research

View BMRN research View TWST research

Metric	BMRN BioMarin Pharmaceutical Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$10.59B	$9.95B
Enterprise Value	$13.90B	$9.83B
Price	$54.80	$159.78
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	23.04x
EV/Sales	4.08x	22.77x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	27.87x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-100.10x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	18.83x
Revenue & Growth
Revenue (TTM)	$3.41B	$432M
Revenue Growth (YoY)	11.2%	19.2%
Forward Rev Growth	14.5%	15.0%
Profitability
Gross Margin (TTM)	79.6%	52.0%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-26.0%
Net Margin (TTM)	2.1%	-31.7%
FCF Margin (TTM)	21.3%	-22.7%
Net Income (TTM)	$73M	$-137M
FCF (TTM)	$725M	$-98M
EPS (TTM)	$0.38	-$2.19
ROE (TTM)	1.2%	-2989.0%
ROA (TTM)	82.0%	-2080.0%
ROIC (TTM)	93.0%	-2989.0%
Financial Health
Cash	$874M	$117M
Debt	$4.19B	$0
Net Cash/Debt	$-3.31B	$117M
Current Ratio (TTM)	2.39x	2.67x
Quick Ratio (TTM)	1.16x	2.30x
Debt/Equity (TTM)	0.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.17
52W Performance	0.2%	387.3%
YTD Performance	-7.8%	393.3%
% from 52W High	-22.8%	-27.3%
% from 52W Low	11.2%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.66x
FCF Yield (TTM)	6.8%	-1.0%
Earnings Yield (TTM)	0.7%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	-3.6
EV/GP/RG	0.18	1.94
Ticker research	View BMRN research	View TWST research

Valuation

P/E Ratio

BMRN

146.03x

P/S Ratio

BMRN

3.11x

TWST

23.04x

EV/FCF

TWST

-100.10x

BMRN

19.17x

Growth & revenue

Revenue Growth TTM

TWST

19.2%

BMRN

11.2%

Forward Revenue Growth

TWST

15.0%

BMRN

14.5%

Profitability & performance

Gross Margin

BMRN

79.6%

TWST

52.0%

ROE

BMRN

1.2%

TWST

-2989.0%

FCF Yield %

BMRN

6.8%

TWST

-1.0%

52-Week Performance

TWST

387.3%

BMRN

0.2%

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

TWST

Twist Bioscience Corp

Market Cap

BMRN$10.59B

TWST$9.95B

Enterprise Value

BMRN$13.90B

TWST$9.83B

Price

BMRN$54.80

TWST$159.78

P/E Ratio

BMRN146.03x

TWSTN/A

P/S Ratio

BMRN3.11x

TWST23.04x

EV/Sales

BMRN4.08x

TWST22.77x

EV/EBITDA

BMRN16.77x

TWST0.00x

P/B Ratio

BMRN1.75x

TWST27.87x

P/FCF Ratio

BMRN14.61x

TWSTN/A

EV/FCF

BMRN19.17x

TWST-100.10x

PEG Ratio

BMRN4.10x

TWSTN/A

Forward P/E (NTM)

BMRN12.82x

TWSTN/A

Forward P/S (NTM)

BMRN2.41x

TWST18.83x

Revenue (TTM)

BMRN$3.41B

TWST$432M

Revenue Growth (YoY)

BMRN11.2%

TWST19.2%

Forward Rev Growth

BMRN14.5%

TWST15.0%

Gross Margin (TTM)

BMRN79.6%

TWST52.0%

Operating Margin (TTM)

BMRN4.4%

TWST0.0%

EBITDA Margin (TTM)

BMRN24.3%

TWST-26.0%

Net Margin (TTM)

BMRN2.1%

TWST-31.7%

FCF Margin (TTM)

BMRN21.3%

TWST-22.7%

Net Income (TTM)

BMRN$73M

TWST$-137M

FCF (TTM)

BMRN$725M

TWST$-98M

EPS (TTM)

BMRN$0.38

TWST-$2.19

ROE (TTM)

BMRN1.2%

TWST-2989.0%

ROA (TTM)

BMRN82.0%

TWST-2080.0%

ROIC (TTM)

BMRN93.0%

TWST-2989.0%

Cash

BMRN$874M

TWST$117M

Debt

BMRN$4.19B

TWST$0

Net Cash/Debt

BMRN$-3.31B

TWST$117M

Current Ratio (TTM)

BMRN2.39x

TWST2.67x

Quick Ratio (TTM)

BMRN1.16x

TWST2.30x

Debt/Equity (TTM)

BMRN0.66x

TWST0.00x

Debt/Assets (TTM)

BMRN0.0%

TWST0.0%

Interest Coverage (TTM)

BMRNN/A

TWSTN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

TWST0.00x

Beta

BMRN0.23

TWST2.17

52W Performance

BMRN0.2%

TWST387.3%

YTD Performance

BMRN-7.8%

TWST393.3%

% from 52W High

BMRN-22.8%

TWST-27.3%

% from 52W Low

BMRN11.2%

TWST585.8%

Asset Turnover (TTM)

BMRN0.38x

TWST0.66x

FCF Yield (TTM)

BMRN6.8%

TWST-1.0%

Earnings Yield (TTM)

BMRN0.7%

TWST-1.4%

Dividend Yield (TTM)

BMRNN/A

TWSTN/A

Rule of 40

BMRN32.5

TWST-3.6

EV/GP/RG

BMRN0.18

TWST1.94

Ticker research

View BMRN research View TWST research

Metric	BMRN BioMarin Pharmaceutical Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$10.59B	$9.95B
Enterprise Value	$13.90B	$9.83B
Price	$54.80	$159.78
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	23.04x
EV/Sales	4.08x	22.77x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	27.87x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-100.10x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	18.83x
Revenue & Growth
Revenue (TTM)	$3.41B	$432M
Revenue Growth (YoY)	11.2%	19.2%
Forward Rev Growth	14.5%	15.0%
Profitability
Gross Margin (TTM)	79.6%	52.0%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-26.0%
Net Margin (TTM)	2.1%	-31.7%
FCF Margin (TTM)	21.3%	-22.7%
Net Income (TTM)	$73M	$-137M
FCF (TTM)	$725M	$-98M
EPS (TTM)	$0.38	-$2.19
ROE (TTM)	1.2%	-2989.0%
ROA (TTM)	82.0%	-2080.0%
ROIC (TTM)	93.0%	-2989.0%
Financial Health
Cash	$874M	$117M
Debt	$4.19B	$0
Net Cash/Debt	$-3.31B	$117M
Current Ratio (TTM)	2.39x	2.67x
Quick Ratio (TTM)	1.16x	2.30x
Debt/Equity (TTM)	0.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.17
52W Performance	0.2%	387.3%
YTD Performance	-7.8%	393.3%
% from 52W High	-22.8%	-27.3%
% from 52W Low	11.2%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.66x
FCF Yield (TTM)	6.8%	-1.0%
Earnings Yield (TTM)	0.7%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	-3.6
EV/GP/RG	0.18	1.94
Ticker research	View BMRN research	View TWST research